Repeatability of quantitative MRI measurements in normal breast tissue.

PURPOSE To evaluate the variability and repeatability of repeated magnetic resonance imaging (MRI) measurements in normal breast tissues between and within subjects. METHODS Eighteen normal premenopausal subjects underwent two contrast-enhanced MRI scans within 72 hours or during the same menstrual phase in two consecutive months. A subset of nine women also completed diffusion-weighted imaging (DWI). Fibroglandular tissue (FGT) density and FGT enhancement were measured on the contrast-enhanced MRI. Apparent diffusion coefficient (ADC) values were computed from DWI. Between- and within-subject coefficients of variation (bCV and wCV, respectively) were assessed. Repeatability of all measurements was assessed by the coefficient of repeatability (CR) and Bland-Altman plots. RESULTS The bCV of FGT density and FGT enhancement at visit 1 and visit 2 ranged from 47% to 63%. The wCV was 13% for FGT density, 22% for FGT enhancement, and 11% for ADC. The CRs of FGT density and FGT enhancement were 0.15 and 0.19, respectively, and for ADC, it was 6.1 x 10(-4) mm(2)/s. CONCLUSIONS We present an estimate of the variability and repeatability of MR measurements in normal breasts. These estimates provide the basis for understanding the normal variation of healthy breast tissue in MRI and establishing thresholds for agreement between measurements.

[1]  G Lutterbey,et al.  Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. , 1997, Radiology.

[2]  D. Plewes,et al.  Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer , 2008, Annals of Internal Medicine.

[3]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[4]  B K Rutt,et al.  Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.

[5]  A. Padhani,et al.  Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis , 2002, NMR in biomedicine.

[6]  D. Altman,et al.  Comparing methods of measurement: why plotting difference against standard method is misleading , 1995, The Lancet.

[7]  Wendy B DeMartini,et al.  Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. , 2008, Academic radiology.

[8]  Mahlon D. Johnson,et al.  Diffusion-weighted imaging for differentiating benign from malignant skull lesions and correlation with cell density. , 2012, AJR. American journal of roentgenology.

[9]  N. Duric,et al.  Volumetric breast density evaluation from ultrasound tomography images. , 2008, Medical physics.

[10]  A Heinig,et al.  Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. , 1997, European journal of radiology.

[11]  S. J. Graham,et al.  Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography. , 1996, British Journal of Cancer.

[12]  James C. Bezdek,et al.  Pattern Recognition with Fuzzy Objective Function Algorithms , 1981, Advanced Applications in Pattern Recognition.

[13]  Alan Jackson,et al.  New hybrid technique for accurate and reproducible quantitation of dynamic contrast‐enhanced MRI data , 2003, Magnetic resonance in medicine.

[14]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007 .

[15]  B. Narin,et al.  Correlation between breast density in mammography and background enhancement in MR mammography , 2010, La radiologia medica.

[16]  A. Localio,et al.  Longitudinal and repeated cross‐sectional cluster‐randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods , 2006, Statistics in medicine.

[17]  N. Boyd,et al.  Breast tissue composition and susceptibility to breast cancer. , 2010, Journal of the National Cancer Institute.

[18]  Jennifer D. Brooks,et al.  Background parenchymal enhancement at breast MR imaging and breast cancer risk. , 2011, Radiology.

[19]  C. Klifa,et al.  Quantification of breast tissue index from MR data using fuzzy clustering , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[20]  M. Yaffe,et al.  Improvement in DCIS Detection Rates by MRI Over Time in a High‐Risk Breast Screening Study , 2011, The breast journal.

[21]  Maryellen L. Giger,et al.  Normal parenchymal enhancement patterns in women undergoing MR screening of the breast , 2011, European Radiology.

[22]  C. Kuhl.  The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. , 2007, Radiology.

[23]  C. Claussen,et al.  Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. , 1997, Radiology.

[24]  W. Kaiser,et al.  Changes in magnetic resonance mammography due to hormone replacement therapy , 2004, Breast Cancer Research.

[25]  G C McKinnon,et al.  Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI , 2001, Journal of magnetic resonance imaging : JMRI.

[26]  J. Listinsky,et al.  Role of MRI in breast cancer management , 2009, Cleveland Clinic Journal of Medicine.

[27]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[28]  Usha Sinha,et al.  In vivo diffusion‐weighted MRI of the breast: Potential for lesion characterization , 2002, Journal of magnetic resonance imaging : JMRI.

[29]  L O Hall,et al.  Review of MR image segmentation techniques using pattern recognition. , 1993, Medical physics.

[30]  Catherine Klifa,et al.  Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort. , 2010, Magnetic resonance imaging.

[31]  N. deSouza,et al.  Diffusion weighted imaging of the normal breast: reproducibility of apparent diffusion coefficient measurements and variation with menstrual cycle and menopausal status , 2012, European Radiology.

[32]  N. Boyd,et al.  Mammographic densities and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  Wendy B DeMartini,et al.  Background parenchymal enhancement on breast MRI: impact on diagnostic performance. , 2012, AJR. American journal of roentgenology.

[34]  C. Kuhl,et al.  MRI of breast tumors , 2000, European Radiology.